Anti-PD 1 Brain Collaboration for Patients With Melanoma Brain Metastases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Clinical Research on the Treatments on Advanced Malignant Melanoma by Combining in Situ Immunotherapy and Laser Therapy
- Status
- COMPLETED
- Phase
- N/A
Study of Pembrolizumab (MK-3475) Versus Placebo After Complete Resection of High-Risk Stage III Melanoma (MK-3475-054/1325-MG/KEYNOTE-054)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Quality of Life and Surgical Late Effects of Melanoma Treatment
- Status
- COMPLETED
- Phase
- N/A
Skin Cancer Screening Education Study
- Status
- UNKNOWN
- Phase
- NA
Study of CM-24 (MK-6018) Alone and In Combination With Pembrolizumab (MK-3475) in Participants With Selected Advanced or Recurrent Malignancies (MK-6018-001)
- Status
- TERMINATED
- Phase
- PHASE1
Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration
- Status
- TERMINATED
- Phase
- N/A
Neoadjuvant Combination Biotherapy With Pembrolizumab and High Dose IFN-alfa2b
- Status
- COMPLETED
- Phase
- PHASE1
Automatic Early Melanoma Detection by Ultrahigh Resolution Three Dimensional Optical Coherence Tomography
- Status
- UNKNOWN
- Phase
- N/A
A Comparison of Matured Dendritic Cells and Montanide® in Study Subjects With High Risk of Melanoma Recurrence
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
An Investigational Immuno-therapy Study to Evaluate Safety and Effectiveness in Patients With Melanoma That Has Spread to the Brain, Treated With Nivolumab in Combination With Ipilimumab, Followed by Nivolumab by Itself
- Status
- COMPLETED
- Phase
- PHASE2
Fluorescence Imaging in Sentinel Lymph Node Biopsy for Breast Cancer and Melanoma
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Phase II Biomarker Study Comparing the Combination of BRAF Inhibitor Dabrafenib With MEK Inhibitor Trametinib Versus the Combination After Monotherapy With Dabrafenib or Trametinib
- Status
- TERMINATED
- Phase
- PHASE2
Spanish Registry of Mohs Surgery
- Status
- COMPLETED
- Phase
- N/A
A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain
- Status
- COMPLETED
- Phase
- PHASE2
PET Imaging of Solid Tumors Using 124I-Humanized 3F8: A Pilot Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Intratumoral CAVATAK (CVA21) and Ipilimumab in Patients With Advanced Melanoma (VLA-013 MITCI)
- Status
- COMPLETED
- Phase
- PHASE1